Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y1 and P2cyc receptors

Thrombosis and Haemostasis

Volumn 84, Issue 3, 2000, Pages 484-491

  Baurand, A ^a   Eckly, A ^a   Bari, N ^a   Leon, C ^a   Hechler, B ^a   Cazenave, J P ^a   Gachet, C ^a  

^a INSERM   (France)

Author keywords

ADP; Platelet aggregation; Purinergic receptors; Refractoriness

Indexed keywords

A3P5P; ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; ADRENALIN; AR C66096; CYCLIC AMP; FURA 2 ACETOXYMETHYL ESTER; PROSTAGLANDIN E1; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CALCIUM SIGNALING; CONTROLLED STUDY; DESENSITIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0033828240     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614049     Document Type: Article

References (39)

1. Molecular mechanisms of membrane receptors desensitization
2. Desensitization of G-protein-coupled receptors in the cardiovascular system
3. Changes in platelet membranes possibly associated with platelet stickiness
4. Studies on the mechanism whereby platelets are clumped by adenosine diphosphate
5. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets
6. ADP receptors on platelets
7. Refractory state of platelet aggregation with major operations
8. ADP-induced refractory state of platelets in vitro (I - Methodological studies on aggregation in platelet rich plasma)
9. ADP-induced refractory state of platelets in vitro (II - Functional and ultra studies on gel filtered platelets)
10. Influence of apyrase on stability of suspensions of washed rabbit platelets
11. Stored platelets release nucleotides as inhibitors of platelet function
12. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39
13. Loss of ATP diphosphohydrolase activity with endothelial cell activation
14. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets
15. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines
16. ADP receptors and clinical bleeding disorders
17. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor null mice
18. No requirement of P2X1 purinoceptors for platelet aggregation
19. The P2Y1 receptor is necessary for adenosine-5'-diphosphate-induced platelet aggregation
20. Molecular basis for ADP-induced platelet activation - II - The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
21. Coactivation of two different G-protein-coupled receptors is essential for ADP-induced platelet aggregation
22. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
23. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel
24. FPL66096: A novel, highly potent and selective antagonist at human platelet P2T-purinoreceptors
25. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors
26. Molecular basis for ADP-induced platelet activation -I- Evidence for three distinct ADP receptors on human platelets
27. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1 activating peptide through the late activation of phosphoinositide 3-kinase
28. The human platelet ADP receptor activates Gi2 proteins
29. Towards a revised nomenclature for P1 and P2 receptors
30. L'agregation plaquettaire: Outil d'investigation clinique et d'etude pharmacologique - Methodologie
31. Purinoreceptors on blood platelets: Further pharmacological and clinical evidence to suggest the presence of two ADP receptors
32. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
33. Agonist action of adenosine triphosphates at the human P2Y1 receptor
34. Role of P2Y1 purinoceptor in ADP-induced platelet activation
35. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation
36. Nucleotides and cd39: Principal modulatory players in hemostasis and thrombosis
37. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
38. Epinephrine-induced aggregation of rabbit platelets refractory to ADP
39. Congenital deficiency of the phospholipase C coupled platelet P2Y1 receptor leads to a mild bleeding disorder